Warning letter
Antiseptica USA: warning letter of Feb 3, 2006
FDA warning letter UCM075788 · Detroit District Office
Key facts
| Reference number | UCM075788 |
|---|---|
| Company | Antiseptica USA |
| Subject | Labeling/Promotional Claims False & Misleading/New Drug/Misbranded |
| Issue date | Feb 3, 2006 |
| Posted date | Feb 3, 2006 |
| Issuing office | Detroit District Office |
| Product type | Drugs |
| CFR sections cited | 333, 310.545(a)(22)(iii) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: